Covered recipient · General Payments record
SAMANTHA J MCINTIRE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$1,022.14
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $358.12 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $130.74 | 5 |
| Novo Nordisk AS | $112.61 | 6 |
| Xeris Pharmaceuticals, Inc. | $48.73 | 3 |
| GlaxoSmithKline, LLC. | $36.42 | 2 |
| Amgen Inc. | $15.99 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.09 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107633586 | CMS |
| ABBVIE INC. | $20.39 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107633588 | CMS |
| ABBVIE INC. | $47.03 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107633590 | CMS |
| ABBVIE INC. | $16.86 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107633592 | CMS |
| ABBVIE INC. | $31.37 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107633594 | CMS |
| Amgen Inc. | $15.99 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117625742 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.63 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086358492 | CMS |
| GlaxoSmithKline, LLC. | $19.96 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773584 | CMS |
| GlaxoSmithKline, LLC. | $16.46 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116406063 | CMS |
| Novo Nordisk Inc | $16.54 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100581004 | CMS |
| Novo Nordisk Inc | $17.54 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100376955 | CMS |
| Novo Nordisk Inc | $23.96 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100617972 | CMS |
| Novo Nordisk Inc | $16.12 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100568976 | CMS |
| Novo Nordisk Inc | $16.07 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100527077 | CMS |
| Novo Nordisk Inc | $22.38 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100445711 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.16 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144637856 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.31 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144637858 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.26 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144637860 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.